Inmazeb Injection, Solution
Product Images NDC 61755-018

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Inmazeb (NDC 61755-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Regeneron Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Inmazeb 01)

A Kaplan-Meier survival curve chart comparing cumulative incidence of death over 29 study days between two groups: INMAZEB and Control. The chart shows a lower cumulative death incidence for INMAZEB (dashed line) compared to Control (solid line). The x-axis represents study days, and the y-axis represents cumulative incidence of death. A table below the graph lists the number of subjects at risk for each group at various time points.*

FDA Label Image

Principal Display Panel (14.5 mL Vial Carton)

Carton label for Inmazeb injection, containing atoltivimab, maftivimab, and odesivimab-ebgn. Each single-dose vial contains 241.7 mg of each antibody per 14.5 mL (16.67 mg/mL per antibody). The product is for intravenous infusion after dilution, distributed by Regeneron Pharmaceuticals, Inc. Storage instructions and dosage information referencing prescribing information are included.*

FDA Label Image

Inmazeb 03

Packaging label for Inmazeb injection solution, containing atoltivimab, maftivimab, and odesivimab-ebgn. Each single-dose vial contains 483.3 mg of each component in 14.5 mL (33.33 mg/mL). The label includes instructions for intravenous infusion after dilution and storage conditions. Manufactured by Regeneron Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.